Top 10 biz headlines: RBI's relaxation for banks, Sensex amid US-Iran issue

From TCS board meeting to NCLAT's Tata-Mistry case, here are the top 10 business headlines for the day

RBI, Reserve bank of india
BS Web Team
3 min read Last Updated : Jan 07 2020 | 7:12 AM IST
RBI's relaxation for banks to lend Rs 3.5 trillion extra set to end
The Reserve Bank of India (RBI) may not extend the relaxation given last year to banks to comply with its capital conservation buffer (CCB) norm of 2.5 per cent by the end of 2019-20 (FY20). The Centre has to take this aspect into account when it pencils in the recapitalisation amount for state-run banks for FY21. Read more.

Sensex falls 788 pts amid US-Iran tensions, Nifty ends below 12,000-mark
Domestic equities slumped on Monday and posted their biggest fall in four months as investors dumped stocks amid worries about the impact of escalating US–Iran tensions on crude oil prices and its implications for the rupee and fiscal deficit. Read more.

Why don't you resolve differences together: SC to Nusli Wadia, Ratan Tata
The Supreme Court on Monday asked Bombay Dyeing Chairman Nusli Wadia and Ratan Tata, chairman emeritus of Tata Sons, to sit together and resolve their differences in a defamation case. Read more.

Synergy Group gives new expression of interest for beleaguered Jet Airways
South America-based Synergy Group has again given a formal Expression of Interest (EoI) for beleaguered Jet Airways, sources said. The latest deadline for EoI applications is January 15, the Committee of Creditors (CoC) had decided at their latest meeting. Read more.

TCS board won't meet on January 9; Q3 results likely after SC hearing
Tata Consultancy Services (TCS) will not be the first one to kick-start the earnings season among information technology (IT) services firms in the third quarter (Q3) of 2019-20. The IT bellwether is learnt to be waiting until the Supreme Court (SC) hears its plea over the National Company Law Appellate Tribunal’s (NCLAT’s) order on the reinstatement of Cyrus Mistry. Read more.

NCLAT upholds its judgment in Tata-Mistry case, dismisses RoC plea
The National Company Law Appellate Tribunal (NCLAT) on Monday dismissed the petition of Registrar of Companies, Mumbai, seeking modifications in the Tata Sons versus Cyrus Mistry judgment, as no mala fide intentions have been made against the government body, its order said. Read more.

Tata Steel 'can't keep funding losses' at UK's Port Talbot plant: Chairman
The chairman of the Tata group N Chandrasekaran has said the steel conglomerate cannot have a situation where India keeps funding the mounting losses at its struggling Port Talbot steelworks in the UK. Read more.

Gold price, valuation hurdle for Titan stock; firm outperforms market
On a day when the broader markets were down 2 per cent, Titan remained the sole large-cap stock in the Sensex ending in the green. The stock was up 1.7 per cent after it announced double-digit sales uptick for its jewellery segment in the December quarter. Read more.

Top cancer drugs may come under price control
Popular biosimilars for cancer cure like bevacizumab or trastuzumab and treatments like immunotherapy may get incorporated in India’s revised National List of Essential Medicines (NLEM), taking cue from the World Health Organisation’s revised list of essential medicines. This brings a whole new set of oncology medicines and treatments under price control, said sources quoted in a report by The Economic Times.

Boeing reassigns 737 Max workers with factory shutdown looming
Boeing Co. has begun handing out new work assignments to the 3,000 workers who will be affected by the temporary production halt as it plans to shut down its 737 Max assembly lines in mid-January, the manufacturer told employees Monday, reports LiveMint.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Curated Content

Next Story